Department of Fundamental Oncology, University of Lausanne, Lausanne, Switzerland.
Ludwig Institute for Cancer Research, University of Lausanne, Epalinges, Switzerland.
Cancer Discov. 2022 Jul 6;12(7):1615-1616. doi: 10.1158/2159-8290.CD-22-0472.
In this issue, Hu and colleagues unveil that IFNα administration combined with anti-PD-1 therapy can potentiate murine and human CD8+ T-cell antitumor response in hepatocellular carcinoma, highlighting a novel therapeutic strategy for hepatocellular carcinoma. See related article by Hu et al., p. 1718 (6) .
本期,胡教授及其同事揭示了 IFNα 联合抗 PD-1 治疗可以增强肝癌模型中 CD8+T 细胞的抗肿瘤反应,为肝癌治疗提供了新的策略。(6)